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doi:10.1016/j.jfma.2012.03.013Background/Purpose: Long-term oxygen therapy has become standard treatment for patients
with chronic respiratory insufficiency. However, patterns of long-term home oxygen therapy
have not been well studied in Taiwan. Oxygen concentrator systems are commonly used in
Taiwan, but liquid oxygen delivery systems are portable and may provide advantages over
the concentrator system. This study compared oxygen usage between patients from a liquid
oxygen group (LOG) and an oxygen concentrator group (OCG). The authors also assessed the
physiologic responses of patients with chronic obstructive pulmonary disease (COPD) to ambu-
latory oxygen use at home.
Methods: The study used a retrospective, cross-sectional, observational survey design. The
LOG comprised 42 patients, and the OCG comprised 102 patients. We recruited participants
in northern Taiwan from July 2009 to April 2010. The questionnaire instruments that were used
to collect data consisted of three parts: demographic characteristics, devices used in respira-
tory care, and activity status with portable oxygen. Two-minute walking tests were performed
on COPD patients in their homes.
Results: COPD was the most common diagnosis in our study, with more than 50% of patients who
received oxygen long term in both groups having received this diagnosis. The LOGused oxygen forterest relevant to this article.
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24 C.-L. Su et al.an average of 21.7 hours per day, whereas OCG averaged 15.2 hours per day (p< 0.001). In the
OCG, 92.2% of patients used a concentrator alone, whereas 23.8% of the LOG used liquid oxygen
alone (p< 0.001). The LOG patients were involved in significantly more outdoors activities
(pZ 0.002) and reported traveling with oxygen more often (p< 0.001) than the OCG patients.
For patients with the same dyspnea level of COPD severity, those using liquid oxygen had a lower
increase in pulse rate after the walking test, in comparison with the concentrator users.
Conclusion: Patients in the LOG used oxygen for longer hours, went on more outings, and were
more likely to travel with oxygen than patients in the OCG. Being ambulatory with liquid oxygen
might enable patients with COPD to walk more effectively.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
A new generation of portable oxygen systems has increased
the options for advanced home care worldwide. Patients
with advanced chronic obstructive pulmonary disease
(COPD) and chronic respiratory failure who previously would
have required hospitalization or institutionalization are now
able to remain at home. The use of homemedical technology
provides a strategy to increase the efficiency of health care.
Currently, delivery modes exist for home oxygen: oxygen
concentrators, liquid oxygen, and oxygen cylinders. Oxygen
concentrators are the most popular source of domiciliary
oxygen used in Taiwan and other countries. The overall cost
of concentrators is low, and refilling oxygen cylinders is
unnecessary. However, concentrators are not versatile and
the cost of electricity is often borne by patients. Few
patients use small portable oxygen cylinders alone. The
limited gas volume, short duration of oxygen supply, and
the cost of having cylinders delivered are major limitations
of portable cylinders. The liquid oxygen system provides
the most flexible source of home oxygen. The light,
portable containers each allow 8e10 hours of ambulatory
use.1,2 However, liquid oxygen is relatively expensive
compared with the other two systems.3
Studies show that patients with COPD who use oxygen for
more than 15 hours per day (preferably more than 20 hours)
have the best survival rate.4,5 The European Respiratory
Society and American Thoracic Society guidelines both advo-
cate24hours of continuousoxygenuseperday, supplemented
with ambulatory capacity.6 However, this suggested standard
is difficult to apply because patients are required to make
a lifelong commitment to a cumbersome oxygen device.
Oxygen devices restrict activities of daily living and affect
patients’ quality of life.6,7 Research has suggested that poor
compliance may result in lower than optimal survival rates
and may increase unnecessary hospitalization.4,8 Some
studies have found that many patients use oxygen for fewer
than 15 hours per day,8,9 and that mobile patients generally
use oxygen for less than the prescribed time.8 Thus,
promoting use of ambulatory oxygen is of utmost importance
in improving the survival rate of patients with COPD.
In Western countries, liquid oxygen is popular for
ambulatory patients who want to spend more time outside
their homes and move around. Studies have reported that
liquid oxygen, in comparison with cylinders or concentra-
tors, is associated with better patient compliance and
longer time spent outside the home.10e12 However, no
comparative study had been conducted in Taiwan to
examine patterns of use for concentrators, liquid, andcylinders. In this study, we hypothesized that the use of
liquid oxygen could improve the duration of therapy,
activity level, and walking outcomes. We compared the
oxygen use of patients in a liquid oxygen group (LOG) and
oxygen concentrator group (OCG). We also assessed the
physiologic responses of patients with COPD to the use of
ambulatory oxygen at home.
Materials and methods
Patients and study design
This was a retrospective, cross-sectional study that used the
observation survey technique. The data were collected from
July 2009 to April 2010. Patients using oxygen at home were
recruited through three major oxygen vendors in northern
Taiwan. The inclusion criteria were as follows: (1) confirmed
primary diagnosis of COPD from the hospital discharge data,
or a COPD diagnosis previously made by the patient’s
physician; (2) stable clinical conditions without experiencing
an acute exacerbation in the month prior to measurement;
and (3) requirement for ambulatory oxygen at home.
The exclusion criteria covered the following conditions:
dementia, concomitant heart failure, diseases associated
with inherent difficulty in mobility, and any medical condi-
tion in which exercise testing was contraindicated according
to the American Thoracic Society guidelines.13,14 The prin-
ciples outlined in the Declaration of Helsinki were
followed in the planning and performing of this research.
Informed consent was obtained from all participants.
Study protocol
The objective of the study was fully explained to patients
by phone, and home visit appointments were arranged. All
patients were required to sign a written consent form.
Patients (or their primary caregivers) were then asked to
complete the questionnaire, and a nurse was available to
clarify the content if required. Each patient was instructed
to read the response statements for the Medical Research
Council (MRC) scale and then select the appropriate
number that best described his or her shortness of breath.
After the walk test location had been selected, the
patient was instructed to read the descriptive statements of
the Borg scale. The walk-test procedure was once again
explained to the patients before performing the modified 2-
minutewalk test (2MWT). The nurse recorded the test results
and filed the printed data generated by the pulse oximeter.
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A three-part questionnaire containing 25 questions was
used to collect data. Part 1 covered basic demographic data
(nine items); Part 2 addressed the devices used in home
respiratory care (six items); and Part 3 consisted of nine
items that covered the patient’s activity status using
portable oxygen (Appendix I). Patients’ diagnoses and
doctor prescriptions were obtained from the hospital
discharge data.
The content of the questionnaire was validated by
a formative committee, which consisted of five oxygen
patients, five homecare nurses, and five chest physicians.
The questions were first answered by the selected five
home oxygen patients. The item wording and sequences
were adjusted, and the questionnaire was then reevaluated
by the home nurses and chest physicians to verify the
content validity. Questions with points higher than 0.8 were
included in the final questionnaire.15
MRC dyspnea scale
The MRC dyspnea scale is used to grade the effect of
breathlessness on daily activies.16 This scale provides
a simple and valid method of categorizing the degree of
disability in patients with COPD.17,18 The current study used
a modified MRC scale,16 namely a five-point scale based on
degrees of various physical activities that precipitate
breathlessness. Higher scores represent greater breath-
lessness. The questionnaire consisted of five statements on
perceived breathlessness, as follows: Grade 1, “I only get
breathless with strenuous exercise”; Grade 2, “I get
shortness of breath when hurrying on level ground or up
a slight hill”; Grade 3, “ I walk slower than people of the
same age on level ground because of breathlessness, or I
have to stop for a breath when walking at my own pace on
level ground”; Grade 4, “I stop for a breath after walking
100 yards or after a few minutes on level ground”; and
Grade 5, “I am too breathless to leave the house.”
Modified 2MWT
The 2MWT is a reliable and valid instrument when used with
Chinese patients with COPD who have moderate to severe
disease. Previous research has found significant correla-
tions between patients’ responses on the 2MWT and the 6-
minute walk test. 19
The patients performed the 2MWT at their homes. We
encouraged each participant after every minute with one of
two phrases: "You are doing well" or "Keep up the good
work." They were allowed to stop and rest during the test,
but were instructed to resume walking as soon as they felt
comfortable to continue. The patients walked with their
usual supply of oxygen by either liquid oxygen or
a concentrator, administered at the usual flow.
We used a pulse oximeter (3301, BCI International Co,
WI, USA) to measure and record data on patients’ pulse rate
(PR) and oxygen saturation (SpO2) every 6 seconds. Data
were printed automatically. The Modified Borg scale20 was
used to evaluate the patient at rest (R) and after walking
(Ex), expressed as RBorg and ExBorg, respectively.21Changes between R and Ex for PR, SpO2, and Borg scores
were then calculated (DPR, DSpO2, and DBorg, respec-
tively). Scores for resting pulse rate (RPR) and resting SpO2
represent the patient’s PR and SpO2 after he or she had
rested completely for 5 minutes, whereas Ex PR and Ex
SpO2 represent PR and SpO2 immediately at the end of a 2-
minute walk. We did not measure the distances patients
walked during the 2-minute test because the patients’
home environments varied widely, and we were thus unable
to establish a standard 30-m straight path.
Statistical analysis
SPSS version 15.0 software (SPSS Inc, Chicago, IL, USA) was
used for statistical analysis. The data were presented
either as the relevant percentage of patients or as mean
score standard deviation (SD). The distribution of cate-
gorical variables across the groups was tested by the chi-
square test .The Student t test for unpaired groups was
used to assess the differences between the groups
regarding 2MWT parameters, and for characteristics
measured as continuous variables. Analysis of variance was
used to further investigate the association among the
variables and the potential risk factors. A p value of less
than 0.05 was considered statistically significant.
Results
Eighty percent of all eligible patients from the three
oxygen vendors we approached agreed to be included in
the study. The survey questionnaire was administered to
155 patients. Eleven patients did not fully complete the
survey and were thus excluded; a final sample of 144
patients was recruited. Of the 88 patients with COPD who
were enrolled, 70 participants (79.5%) successfully
completed the 2MWT.
Basic characteristics of patients
The sample comprised 42 liquid oxygen (LOG) patients and
102 oxygen concentrator (OCG) patients. Table 1 lists the
basic characteristics of all study participants. The most
common diagnosis in both groups was COPD, followed by
interstitial lung disease (28.6%), which was significantly
higher in LOG patients (p< 0.001), and neuromuscular
disease (8.8%), which was higher in OCG patients
(pZ 0.047). The overall diagnoses showed significant
differences (p< 0.001) between groups.
Both education and marital status differed significantly
between the groups; a significantly higher number of LOG
patients had an educational level of “university or above”
(pZ 0.003). More LOG patients were married than OCG
patients (pZ 0.044). No significant differences were noted
between the two groups for age, height, weight, sex,
number of children, and status of the primary caregiver.
Devices used in respiratory care
The comparison between the LOG and OCG regarding
devices used in respiratory care is shown in Table 2. The
Table 1 Demographic characteristics of patients using home oxygen.
OCG (nZ 102) LOG (nZ 42) p value
Age (y) 60.2 18.5 65.4 14.9 0.109
Sex M/F 54/48 24/18 0.646
Height (cm) 158.0 13.1 160.5 9.9 0.277
Weight (kg) 54.5 16.7 55.4 12.2 0.746
Diagnosis <0.001*
COPD 66 (64.7) 22 (52.4) 0.168
Restrictive lung diseases 6 (5.9) 2 (4.8) 0.790
Neuromuscular diseases 9 (8.8) 0 (0.0) 0.047*
Cardiovascular diseases 15 (14.7) 2 (4.8) 0.093
Cancer 3 (2.9) 4 (9.5) 0.095
Interstitial lung diseases 3 (2.9) 12 (28.6) <0.001*
Education 0.014*
None 11 (10.8) 8 (19.0) 0.183
Primary school 32 (31.4) 12 (28.6) 0.740
Junior school 15 (14.7) 3 (7.1) 0.212
High school 31 (30.4) 7 (16.7) 0.089
College 10 (9.8) 5 (11.9) 0.708
University or above 3 (2.9) 7 (16.7) 0.003*
Marital status 0.045*
Married 71 (69.6) 36 (85.7) 0.044
Never married 23 (22.5) 3 (7.1) 0.029
Divorced 1 (1.0) 2 (4.8) 0.149
Widowed 7 (6.9) 1 (2.4) 0.286
Have children 82 (80.4) 37 (88.1) 0.267
Primary caregivers 0.057
Parents 19 (18.6) 4 (9.5)
Spouse 30 (29.4) 20 (47.6)
Children 25 (24.5) 13 (31.0)
Other relatives 9 ( 8.8) 1 (2.4)
Hire people to take care 14 (13.7) 3 (7.1)
Friend 0 (0.0) 1 (2.4)
None 5 (4.9) 0 (0.0)
Data are represented as n (%) or mean standard deviation. *p< 0.05. COPDZ chronic obstructive pulmonary disease; LOGZ liquid
oxygen group; OCGZ oxygen concentrator group.
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home respiratory care devices was more than 2 years in
both groups. The LOG patients tended to use only oxygen
without a ventilator (66.7% of LOG patients without
ventilator) (p< 0.001), whereas OCG patients used
significantly more ventilator support than did the LOG
patients (72.5% of OCG patients ventilator usage). A
higher percentage of OCG patients had undergone
tracheotomy (pZ 0.003). Differences in the type of
oxygen source reached a level of statistical significance
(p< 0.001) with the following findings: 73.8% of LOG
patients used both liquid and concentrator; 23.8% of LOG
patients used liquid only; and 92.2% of OCG patients used
only the concentrator.
The use of a nasal cannula with demand flow was rela-
tively common in 90.5% of LOG patients (p< 0.001), and
67.6% of OCG patients used a nasal cannula only
(p< 0.001). Oximeter monitors were used by 61.9% of LOG
patients but by only 29.4% of OCG patients (p< 0.001).
When asked to rate the need for home service, significantly
more LOG than OCG patients expressed the view that home
service was not necessary (pZ 0.009).Patterns of domestic activity and ambulatory
oxygen usage
Table 3 lists the patterns of oxygen usage. The MRC scores
were similar for both groups. The LOG patients used oxygen
for a longer period each day, at 21.7 hours/day (p< 0.001).
The two groups differed significantly for reported frequencies
of outings (pZ 0.002). More OCG patients reported “0 to 1”
outings perweek (p< 0.001), andmoreLOGpatients reported
“10 or more” per week (pZ 0.012). More LOG patients re-
ported that they had been traveling with oxygen (p< 0.001).
However, after covariance adjustments (Table 4, the
outcomes ofmotivation for outingwere not affected by liquid
oxygen. We also found the pattern of oxygen use differed
significantly between the two groups (pZ 0.006), with
a higher percentage of LOG patients using oxygen during
activity (pZ 0.003) or at both “rest and activity” (pZ 0.027).
The heaviness of the oxygen source was cited as
a limiting factor for going outdoors by more OCG than LOG
patients (32.4% and 14.3%, respectively) (pZ 0.027). A
higher percentage of LOG patients reported two limiting
factors (p< 0.001), whereas more OCG patients reported
Table 2 Devices used in respiratory care.
OCG (nZ 102) LOG (nZ 42) p value
Treatment time (mo) 30.8 43.0 25.7 31.0 0.490
Ventilator usage 74 (72.5) 14 (33.3) <0.001*
Tracheostomy 23 (22.5) 1 (2.4) 0.003*
Oxygen source <0.001*
Liquid only 0 (0.0) 10 (23.8) <0.001*
Concentrator only 94 (92.2) 0 (0.0) <0.001*
Liquid and concentrator 0 (0.0) 31 (73.8) <0.001*
Concentrator and cylinder 8 (7.8) 0 (0.0) 0.062
All three 0 (0.0) 1 (2.4) 0.118
Oxygen device <0.001*
Nasal cannula 69 (67.6) 3 (7.1) <0.001*
Simple mask 4 (3.9) 1 (2.4) 0.646
Tracheal mask 16 (15.7) 0 (0.0) 0.007*
No device 9 (8.8) 0 (0.0) 0.047*
Nasal and mask 4 (3.9) 0 (0.0) 0.193
Nasal demand flow 0 (0.0) 38 (90.5) <0.001*
Oximeter monitor 30 (29.4) 26 (61.9) <0.001*
Requirement for home health care services 0.014*
Extremely necessary 35 (34.3) 8 (19.0) 0.069
Necessary 44 (43.1) 13 (31.0) 0.174
Depends 14 (13.7) 11 (26.2) 0.727
Not necessary 8 (7.8) 10 (23.8) 0.009*
Does not help and increases cost 1 (1.0) 0 (0.0) 0.520
Data are represented as n (%) or mean standard deviation. *p< 0.05. LOGZ liquid oxygen group; OCGZ oxygen concentrator group.
The use of domiciliary oxygen in northern Taiwan 27three limiting factors deterring them from going outdoors
(pZ 0.02). The differences between the two groups for the
limiting factors cited reached a level of significance
(pZ 0.001).
2MWT for patients with COPD
A total of 19 LOG patients and 51 OCG patients performed
the 2MWT with an oxygen supply. Patient characteristics,
MRC scale rating, and oxygen flow rate during walking were
similar for both groups, as shown in Table 5. However,
a higher percentage of LOG patients did not use a ventilator
(pZ 0.024). The RSpO2 and RBorg were the same, but RPR
differed significantly between the groups, with LOG
patients having a higher RPR (83.3  2.7 beats/minute for
OCG, 94.2  5.8 beats/minute for LOG; pZ 0.006). The
ExPR, ExSpO2, and ExBorg at the end of the walking test
were similar between groups. The groups showed a statis-
tically significant difference for DPR (P< 0.001), but DSpO2
and DBorg were similar for both groups. Covariance
adjustments confirmed the benefits on pulse rate change
during walking when patients used liquid oxygen (Table 6).
Discussion
The MRC trial4 and the Nocturnal Oxygen Therapy Trial
(NOTT)5 suggested that a minimum of 15 hours of daily
oxygen supplementation was vital to prolong life in patients
who require oxygen therapy. The European Society of
Pneumology Task Group agreed that 15 hours should be the
minimum duration of daily oxygen use, and that the benefits
of long-term oxygen therapy depend on the daily duration ofoxygen use.22 Our own study patients, whether using
concentrators or liquid oxygen, reportedly used oxygen
therapy for at least 15 hours per day. However, LOG patients
used oxygen for significantly longer periods than did OCG
patients. Previous research has suggested that the use of
liquid oxygen, either alone or together with other oxygen
sources, could increase oxygen therapy compliance and thus
increase the benefits of long-term oxygen therapy.8
The MRC and NOTT studies indicated that long-term
oxygen therapy improves the survival of patients with
COPD4,5; however, no clinical trials have been done on
patients without COPD.4,5 Medicare data for 1991 and 199223
indicate that COPD is the most common diagnosis in patients
who use oxygen in the United States. Our sample in northern
Taiwan showed the same pattern. Furthermore, a relatively
large number of LOGpatients in our study had interstitial lung
disease. Patients with interstitial lung disease require a high
oxygen flow,24 and this high demand promotes the selection
of liquid oxygen over a concentrator.
Patients in our LOG were significantly more active in
outdoor activities, for both the frequency of outing and
traveling with oxygen. Our findings indicated that LOG
patients experienced an enhanced quality of life relative to
OCG patients. Patients in the LOG tended to desire to go
outdoors more than did OCG patients. Our results also
demonstrated that patients with COPD may benefit from
portable liquid oxygen because of the improved pulse rate
change that was evident during the 2MWT (Table 5).
Bestall et al17 used MRC grades 3 to 4 as the major deter-
minants of disability for exercise performance inpatientswith
COPD.17 In our study, theMRC grades of all patientswith COPD
were between 3 and 4. Those patients with COPD in the LOG
whohadMRCgrades3 and4displayed significantly less change
Table 3 Patients’ MRC scale rating and patterns of oxygen use.
OCG (nZ 102) LOG (nZ 42) p value
MRC scale rating 3.3 1.7 3.4 1.0 0.814
Oxygen usage (h/day) 15.2 7.3 21.7 5.0 <0.001*
Total time spent outdoors (h/day) 0.133
None 16 (15.7) 6 (14.3)
<4 h 66 (64.7) 20 (47.6)
4e8 h 19 (18.6) 15 (35.7)
8e12 h 1 (1.0) 1 (2.4)
Outings frequency (times/wk) 0.002*
0e1 50 (49.0) 7 (16.7) <0.001*
2e3 20 (19.6) 9 (21.4) 0.804
4e6 18 (17.6) 11 (26.2) 0.245
7e9 7 (6.9) 6 (14.3) 0.158
10 or more 7 (6.9) 9 (21.4) 0.012*
Travel with oxygen (times/y) 0.3 0.6 4.5 11.1 <0.001*
Enhanced motivation to go outdoors 60 (58.8) 37 (88.1) <0.001*
Pattern of oxygen use 0.006*
Rest, activities, and sleep 82 (80.4) 33 (78.6) 0.804
Rest only 1 (1.0) 0 (0.0) 0.520
Activities only 1 (1.0) 5 (11.9) 0.003*
Sleep only 8 (7.8) 0 (0.0) 0.062
Rest and activities 0 (0.0) 2 (4.8) 0.027*
Rest and sleep 6 (5.9) 1 (2.4) 0.375
Activities and sleep 4 (3.9) 1 (2.4) 0.646
Oxygen flow rate at resta 2.5 1.3 2.8 1.7 0.426
Oxygen flow rate at sleepb 2.5 1.2 2.8 1.5 0.364
Factors that limit going outdoors 0.001*
None 15 (14.7) 9 (21.4) 0.325
Not enough oxygen supply time 31 (30.4) 14 (33.3) 0.729
Not enough cylinders 2 (2.0) 0 (0.0) 0.361
Oxygen too heavy 33 (32.4) 6 (14.3) 0.027*
Two of the above 9 (8.8) 13 (31.0) <0.001*
All three of the above 12 (11.8) 0 (0.0) 0.020*
Data are represented as n (%) or mean standard deviation.
*p< 0.05. LOGZ liquid oxygen group; OCGZ oxygen concentrator group.
a Number of patients in OCG:LOGZ 88:26.
b Number of OCG:LOGZ 100:31.
28 C.-L. Su et al.in PR during the walking test, even when their RPR had been
higher. In addition, compared with OCG patients, our LOG
patients with COPD experienced no change in resting oxygen
saturation or sensation of breathlessness. We tested walking
status bymeasuringwalking time rather thanwalking distance
because we could not measure distances accurately in the
patients’ homes. Nonetheless, the changes in PRwe observedTable 4 Analysis of covariance in patients with home oxygen (
Factors (df)/outcomes Oxygen
usage (h/day)
Outings freq
(times/w
F value p value F value p
MRC scale rating (1/133) 7.268 0.008* 10.334
Ventilator usage (1/133) 0.041 0.839 0.573
Tracheostomy (1/133) 45.152 <0.001* 6.258
Diagnosis (5/133) 1.762 0.125 0.468
Education (1/133)a 1.852 0.176 0.921
Liquid oxygen (1/133) 41.331 <0.001* 16.911 <
Education was divided into two levels: “University or college” and “low
a Education was divided into two levels: “University or college” andduring the 2MWT may provide a reliable clinical measure of
exercise performance in patients with moderate to severe
COPD.19 Thus, we surmised that patients may increase their
activity levels and use of oxygen when provided with liquid
oxygen.10
Leach et al25 conducted a prospective, randomized
multicenter trial comparing oxygen concentrators withnZ 144).
uency
k)
Travel with
oxygen (times/y)
Enhanced motivation
to go outdoors
value F value p value F value p value
0.002* 1.272 0.261 1.810 0.181
0.451 0.125 0.724 0.026 0.872
0.014* 0.000 0.989 2.581 0.111
0.800 1.462 0.207 2.678 0.024*
0.339 1.993 0.160 0.075 0.784
0.001* 7.308 0.008* 2.389 0.125
er than university”. * p< 0.05. MRCZMedical Research Council.
“lower than university”.
Table 5 Two-minute walking test of patients with COPD.
Item OCG
(nZ 51)
LOG
(nZ 19)
p value
Characteristics
Age (y) 62.6 15.2 69.3 9.4 0.077
Sex M/F 25/26 13/6 0.147
Height (cm) 160.6 9.6 160.6 6.5 0.981
Weight (kg) 55.3 14.6 52.0 9.5 0.370
Ventilator usage 34 (66.7) 7 (36.9) 0.024*
Tracheostomy 11/51 (21.6) 1/19(5.3) 0.108
MRC scale rating 3.3 1.2 3.1 0.9 0.525
Response
Oxygen flow
rate (L/min)a
3.0 1.2 2.6 1.7 0.260
Rest SpO2 (%) 94.6 2.8 94.3 2.3 0.668
Exercise SpO2 (%) 88.8 5.3 88.4 5.0 0.738
DSpO2 (%)
b 5.8 4.2 6.0 4.7 0.888
Rest PR (beats/min) 83.8 12.7 94.2 15.8 0.006*
Exercise
PR (beats/min)
102.8 13.6 102.1 17.7 0.843
DPR (beats/min)b 19.1 9.7 7.8 5.5 <0.001*
Rest Borg 2.9 1.1 3.0 1.4 0.850
Exercise Borg 5.7 1.9 5.3 1.8 0.430
DBorgb 2.7 1.6 2.3 1.5 0.286
Data are represented as n (%) or mean SD. *p< 0.05.
COPDZ chronic obstructive pulmonary disease; LOGZ liquid
oxygen group; MRCZMedical Research Council; OCGZ oxygen
concentration group; PRZ pulse rate; SpO2Z oxygen saturation.
a Oxygen flow rate during walking.
b DZchange in score (exercise score minus rest score).
The use of domiciliary oxygen in northern Taiwan 29liquid oxygen during a 6-month period. The results showed
significant differences in favor of the liquid oxygen group in
the following categories or dimensions: physical function,
ambulation, social interaction, and total Sickness Impact
Profile (SIP) score.25 Our findings also showed that liquid
oxygen increases patients’ activity at home; a higher
percentage of LOG patients used ambulatory oxygen during
both rest and activity. However, the difference between
the LOG and OCG for total duration of time spent outdoors
did not reach a level of significance in our study.
A European 8-week, double-blind, placebo-controlled
study using cylinder oxygen versus cylinder air suggested
that ambulatory oxygen appears to enhance activities, and
that patients need time to learn how to use an oxygen
cylinder.26 It suggested that patients are likely to benefit
from using ambulatory oxygen after they have learned ofTable 6 Analysis of covariance in patients with COPD
(nZ 70).
Factors (d.f.)/
outcomes
Rest pulse rate DPR (beats/min)
F value p value F value p value
MRC scale rating (1/65) 3.424 0.069 0.306 0.582
Ventilator usage (1/65) 1.578 0.213 0.990 0.323
Tracheostomy (1/65) 0.092 0.763 1.016 0.317
Liquid oxygen (1/65) 11.521 0.001* 21.661 <0.001*
* p< 0.05.
COPDZ chronic obstructive pulmonary disease; DPRZ exercise
pulse rateminus rest pulse rate; MRCZMedical Research Council.the cylinder. Our findings that LOG patients went out of the
home more and traveled more were consistent with these
suggestions. However, ambulatory devices such as small gas
cylinders and battery-powered compact concentrators are
available for OCG patients to use in vehicles or outdoors.
Such substitutes might explain our finding that both LOG
and OCG patients spent similar lengths of time outdoors.
A study conducted with limited data from the French
ANTADIR registry advocates the use of liquid oxygen for
selected patients who wish to be mobile.8 In the United
States, a liquid oxygen system is used to improve patient’s
mobility.27 We compared our data to those of a 1991e1992
home oxygen therapy study among US Medicare beneficia-
ries. 23 In our study, 6.9% of patients (10 of 144) used liquid
oxygen only, which was slightly lower than the 9.5e13.9% of
patients reported by Medicare.23 We believe the cost of
liquid oxygen in northern Taiwan is a determining factor in
such decisions. Fewer of our participants used portable
systems (50 of 144 used 42 liquid and 8 cylinder, 34.7%)
compared with Medicare participants (58%), and more of our
participants used only a concentrator (92.2% vs. 80%).23
Although cultural beliefs and reimbursement fees for
oxygen differ between the United States and Taiwan, the
characteristics of study participants in our study may have
been similar to those reported by Leach et al.25 They found
that liquid oxygen use was associated with people who lived
in nonmetropolitan areas and tended to be white collar
workers, whereas we found that liquid oxygen users tended
to have higher educational levels, and were usually married.
Limitations
Our study had several limitations. First, we did not have
access to data on the patients’ initial arterial blood gas
analysis; hence, we presumed that all our participants met
the criteria for long-term oxygen therapy. Second, we used
the 2MWT to compare the beneficial effects of ambulatory
oxygen administered either in liquid form or through
a concentrator. However, the 2MWT did not test the real-life
tolerability of oxygen devices for portability and ambulatory
design.28,29 Therefore, we had insufficient evidence to draw
firm conclusions about the efficacy of liquid oxygen. Third,
the possible influence of the cost of different types of
oxygen supply and the patients’ home environments was not
studied, and further investigation of both these factors is
needed. Fourth, the acuity level of patient condition differs
between LOG and OCG. Thus, selection bias may have
played a role when physicians decided which type of oxygen
therapy to prescribe for their patients.
Conclusion
Patients using liquid oxygen went out of the home more
often and demonstrated longer periods of daily oxygen
use compared with patients using concentrators. Our
findings for pulse rate change suggested that an ambu-
latory supply of portable liquid oxygen may enhance the
domiciliary walking of patients with COPD. We recom-
mend that health care practitioners consider ambulatory
liquid oxygen for patients who want to be active and for
patients seeking the benefits of physical reconditioning.
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